메뉴 건너뛰기




Volumn 90, Issue 7, 2005, Pages 988-990

An enzyme-linked immunosorbent assay to screen for inhibitors of the oncogenic anaplastic lymphoma kinase

Author keywords

ALCL; ALK; Inhibitor screening; Kinase assay

Indexed keywords

7 HYDROXYSTAUROSPORINE; ADAPHOSTIN; ADENOSINE TRIPHOSPHATE; AG 957; ANAPLASTIC LYMPHOMA KINASE; NSC 689857; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN INHIBITOR; STAUROSPORINE; UNCLASSIFIED DRUG;

EID: 22544432584     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (15)

References (9)
  • 1
    • 0031008896 scopus 로고    scopus 로고
    • ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)
    • Morris SW, Naeve C, Mathew P, James PL, Kirstein MN, Cui X, et al. ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK). Oncogene 1997;14:2175-88.
    • (1997) Oncogene , vol.14 , pp. 2175-2188
    • Morris, S.W.1    Naeve, C.2    Mathew, P.3    James, P.L.4    Kirstein, M.N.5    Cui, X.6
  • 2
    • 0028198206 scopus 로고
    • Fusion of a kinase gene, ALK, to a nucleolar protein gene. NPM. In non-Hodgkin's lymphoma
    • Morris SW, Kirstein Mol. Fusion of a kinase gene, ALK, to a nucleolar protein gene. NPM. in non-Hodgkin's lymphoma. Science 1994;263:1281-4.
    • (1994) Science , vol.263 , pp. 1281-1284
    • Morris, S.W.1    Mol, K.2
  • 3
    • 2342635959 scopus 로고    scopus 로고
    • Anaplastic lymphoma kinase proteins in growth control and cancer
    • Pulford K, Morris SW, Turturro F. Anaplastic lymphoma kinase proteins in growth control and cancer. J Cell Physiol 2004;199:330-58.
    • (2004) J Cell Physiol , vol.199 , pp. 330-358
    • Pulford, K.1    Morris, S.W.2    Turturro, F.3
  • 4
    • 0035419348 scopus 로고    scopus 로고
    • Role of signal transducer and activator of transcription 5 in nucleophosmin/anaplastic lymphoma kinase-mediated malignant transformation of lymphoid cells
    • Nieborowska-Skorska M, Slupianek A, Xue L, Zhang Q, Raghunath PN, Hoser G, et al. Role of signal transducer and activator of transcription 5 in nucleophosmin/anaplastic lymphoma kinase-mediated malignant transformation of lymphoid cells. Cancer Res 2001;61:6517-23.
    • (2001) Cancer Res , vol.61 , pp. 6517-6523
    • Nieborowska-Skorska, M.1    Slupianek, A.2    Xue, L.3    Zhang, Q.4    Raghunath, P.N.5    Hoser, G.6
  • 5
    • 0031755958 scopus 로고    scopus 로고
    • Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity
    • Bai RY, Dieter P, Peschel C, Morris SW, Duyster J. Nucleophosmin- anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity. Mol Cell Biol 1998;18:6951-61.
    • (1998) Mol Cell Biol , vol.18 , pp. 6951-6961
    • Bai, R.Y.1    Dieter, P.2    Peschel, C.3    Morris, S.W.4    Duyster, J.5
  • 6
    • 0034672140 scopus 로고    scopus 로고
    • Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway
    • Bai RY, Ouyang T, Miething C, Morris SW, Peschel C, Duyster J. Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway. Blood 2000;96:4319-27.
    • (2000) Blood , vol.96 , pp. 4319-4327
    • Bai, R.Y.1    Ouyang, T.2    Miething, C.3    Morris, S.W.4    Peschel, C.5    Duyster, J.6
  • 8
    • 0033973544 scopus 로고    scopus 로고
    • Effects of the bcr/abl kinase inhibitors AG957 and NSC 680410 on chronic myelogenous leukemia cells in vitro
    • Svingen PA, Tefferi A, Kottke TJ, Kaur G, Narayanan VL, Sausville EA, et al. Effects of the bcr/abl kinase inhibitors AG957 and NSC 680410 on chronic myelogenous leukemia cells in vitro. Clin Cancer Res 2000;6:237-49.
    • (2000) Clin Cancer Res , vol.6 , pp. 237-249
    • Svingen, P.A.1    Tefferi, A.2    Kottke, T.J.3    Kaur, G.4    Narayanan, V.L.5    Sausville, E.A.6
  • 9
    • 0035871444 scopus 로고    scopus 로고
    • Phase I trial of 72-hour continuous infusion of UCN-01 in patients with refractory neoplasms
    • Sausville EA, Arbuck SG, Messmann R, Headlee D, Bauer KS, Lush RM, et al. Phase I trial of 72-hour continuous infusion of UCN-01 in patients with refractory neoplasms. J Clin Oncol 2001;19:2319-33.
    • (2001) J Clin Oncol , vol.19 , pp. 2319-2333
    • Sausville, E.A.1    Arbuck, S.G.2    Messmann, R.3    Headlee, D.4    Bauer, K.S.5    Lush, R.M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.